期刊文献+

VEGF-C、VEGFR-3和MMP-2在宫颈癌组织中的表达及其与侵袭、转移的关系 被引量:5

Expressions of VEGF-C,VEGFR-3 and MMP-2 in cervical carcinoma and their relationship with invasion and metastasis of cervical carcinoma tissues
原文传递
导出
摘要 目的:探讨血管内皮生长因子C(VEGF-C)及其受体VEGFR-3和基质金属蛋白酶-2(MMP-2)在人宫颈癌组织中的表达及其与宫颈癌侵袭、转移的关系。方法:采用免疫组化SP法检测11例正常宫颈组织、19例CIN组织、47例宫颈癌组织中的VEGF-C、VEGFR-3和MMP-2的表达,分析表达结果与病理特征的关系。结果:VEGF-C、VEGFR-3和MMP-2在正常宫颈组织、CIN组织及宫颈癌组织中的表达依次增高(P<0.05);伴盆腔淋巴结转移组VEGF-C、VEGFR-3和MMP-2的表达较无淋巴结转移组明显升高(P<0.05);浸润宫颈深度≥1/2组VEGF-C、VEGFR-3和MMP-2的表达明显高于浸润宫颈深度<1/2组(P<0.05)。结论:VEGF-C、VEGFR-3和MMP-2蛋白的异常表达在宫颈癌发生发展及侵袭、转移过程中起重要作用,联合检测这些指标有助于预测宫颈癌组织的侵袭和转移。 Objective:To explore the expressions of vascular endothelial growth factor C(VEGF-C),VEGF receptor-3(VEGFR-3)and matrix metalloproteinase-2(MMP-2)in human cervical carcinoma and their relationship with invasion and metastasis of cervical carcinoma tissues.Methods:Immunohistochemical S-P method was used to detect the expressions of VEGF-C,VEGFR-3 and MMP-2 in 11 cases of normal cervical tissues,19 cases of CIN tissues and 47 cases of cervical carcinoma tissues,the relationship between expressions of VEGF-C,VEGFR-3 and MMP-2 and pathological characteristics was analyzed.Results:The expression levels of VEGF-C,VEGFR-3 and MMP-2 increased gradually from normal cervical tissues,CIN tissues to cervical carcinoma tissues(P0.05);the expression levels of VEGF-C,VEGFR-3 and MMP-2 in pelvic lymph node metastasis group were significantly higher than those in non-pelvic lymph node metastasis group(P0.05);the expression levels of VEGF-C,VEGFR-3 and MMP-2 in cervical invasive depth≥1/2 group were significantly higher than those in cervical invasive depth1/2 group(P0.05).Conclusion:The abnormal expressions of VEGF-C,VEGFR-3 and MMP-2 may play an important role in the occurrence,development,invasion and metastasis of cervical carcinoma,joint detection of the indexes may help to predict invasion and metastasis of cervical carcinoma tissues.
出处 《中国妇幼保健》 CAS 北大核心 2010年第36期5384-5386,共3页 Maternal and Child Health Care of China
关键词 宫颈癌 VEGF-C VEGFR-3 MMP-2 免疫组织化学 Cervical carcinoma Vascular endothelial growth factor-C Vascular endothelial growth factor receptor-3 Matrix metalloproteinase-2 Immunohistochemistry
  • 相关文献

参考文献7

  • 1George ML, Tutton MG, Janssen F, et al. VEGF-A, VEGF -C, and VEGF- D in colorectal cancer progression [ J ]. Neoplasia, 2004, 3 (5) : 420.
  • 2Warnberg HNordgren, Bergkvist L, Jeon HS, et al. Tumor markers in breast carcinoma correlate with grade rather than with invasiveness [ J ]. British Journal of Cancer, 2001, 85 (6): 869.
  • 3Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor limp angiogenesis by VEGF - C promotes breast cancer metastasis [ J ]. Nat Med, 2001, 7 (2): 192.
  • 4Van PO, Steele D, Lowe DG, et al. Expression of vascular endothelial growth factor VEGF - C and VEGF - D, and their receptor VEGFR -3, during different stages of cervical carcinogenesis [ J] . J Pathol, 2003, 201 (4) : 544.
  • 5Ohta Y, Shridhar V, Bright RK, et al. VEGF and VEGF type C play an important role in angiogensis and lymphangiogenesis in human malignant mesothelioma tumours [J] . Br J Cancer, 1999, 81 (1) : 54.
  • 6Karkkainen MJ, Makinen T, Alitalo K, et al. Lymphatic endothelium: a new frontier of metastasis research [ J] . Nat Cell Biol, 2002, 4 ( 1 ) : 2.
  • 7Davidson B, Dberg I, Kopolovic J, et al. MMP -2 and TIMP -2 ex- pression correlates with poor prognosis in cervical carcinoma - a clinic pathologic study using immunohistochemisty and mRNA in situ hybridiza- tion[J] . Gynecol Oncol, 1999, 73 (3): 372.

同被引文献47

  • 1徐海燕,辛晓燕.人乳头瘤病毒感染与宫颈癌的研究进展[J].中国妇幼健康研究,2007,18(5):436-440. 被引量:10
  • 2李敏,王文福,汪青.宫颈癌中MMP-2及TIMP-2的表达及其临床意义[J].解剖与临床,2004,9(4):241-243. 被引量:7
  • 3周琦,叶学正,唐郢.survivin与宫颈癌前病变及宫颈癌关系的研究[J].重庆医学,2006,35(5):427-429. 被引量:3
  • 4Uchida H, Tanaka T, Sasaki K, et al. Adenovirus - mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo [J] . Mol Ther, 2004, 10 (1) : 162.
  • 5Belotti D, Paganoni P, Manenti L, et al. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells complications forascites for- mation [J]. Cancer Ras, 2003, 63 (17) : 5224.
  • 6Parkin DM. Global cancer statistics in the year 2000 [J] . Lancet On- col, 2001, 2 (9): 533.
  • 7Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer therapy : fulfilled promises and open questions [ J ]. Careinogenesis, 2007, 28 (6) : 1133.
  • 8Lee JP, Chang KH, Han JH, et al. Survivin, a novel antiapoptosis in- hibitor, expression in uterine cervical cancer and relationship with prog- nostic factors [J] . Int J Gynecol Cancer, 2005, 15 (1) : 113.
  • 9Nasr M, Ayyad SB, El- Lamie IK, et al. Expression of matrix metal- loproteinase - 2 in preinvasive and invasive carcinoma of the uterine cervix [J] . Eur J Gynaecol Oncol, 2005, 26 (2) : 199.
  • 10Ahuja HS,Szanto A,Nagy L,et al.The retinoid X receptor and its ligands:versatile regulators of metabolic function,cell differentiation and cell death[J].J Biol Homeost Agents,2003;17(1):29-45.

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部